GB2092614A - Process for the manufacture of hybrid cells producing an antibody in which methylcellulose is used in the selection of hydrides - Google Patents
Process for the manufacture of hybrid cells producing an antibody in which methylcellulose is used in the selection of hydrides Download PDFInfo
- Publication number
- GB2092614A GB2092614A GB8202247A GB8202247A GB2092614A GB 2092614 A GB2092614 A GB 2092614A GB 8202247 A GB8202247 A GB 8202247A GB 8202247 A GB8202247 A GB 8202247A GB 2092614 A GB2092614 A GB 2092614A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hybrids
- mice
- antibody
- hybridised
- myeloma cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3102772 | 1981-01-28 | ||
| DE3122832 | 1981-06-09 | ||
| DE3143379 | 1981-11-02 | ||
| DE19823200657 DE3200657A1 (de) | 1981-01-28 | 1982-01-12 | Verfahren zur herstellung von einen antikoerper produzierenden hybridzellen und von antikoerpern, hybridzellen und antikoerper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB2092614A true GB2092614A (en) | 1982-08-18 |
Family
ID=27432623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8202247A Withdrawn GB2092614A (en) | 1981-01-28 | 1982-01-27 | Process for the manufacture of hybrid cells producing an antibody in which methylcellulose is used in the selection of hydrides |
Country Status (5)
| Country | Link |
|---|---|
| DK (1) | DK37382A (fi) |
| FI (1) | FI820200A7 (fi) |
| FR (1) | FR2498626A1 (fi) |
| GB (1) | GB2092614A (fi) |
| SE (1) | SE8200403L (fi) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0096839A1 (en) * | 1982-06-09 | 1983-12-28 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for producing human antibody |
| EP0122628A3 (en) * | 1983-04-15 | 1986-03-26 | Amgen Inc. | Monoclonal antibodies to human immune interferon |
| EP0119859A3 (en) * | 1983-03-18 | 1986-12-17 | Kyowa Hakko Kogyo Kabushiki Kaisha | Monoclonal antibodies, processes for their preparation and methods for their use |
| GB2194240A (en) * | 1986-07-25 | 1988-03-02 | Hayashibara Biochem Lab | Preparation of interferon-gamma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3884758A (en) * | 1974-01-30 | 1975-05-20 | Massachusetts Inst Technology | Triglyceride-accumulating clonal cell line |
| GB1540579A (en) * | 1975-08-01 | 1979-02-14 | Searle & Co | Cell culture medium |
| FR2492842A1 (fr) * | 1980-10-24 | 1982-04-30 | Centre Nat Rech Scient | Hybride cellulaire produisant un anticorps specifique de l'interferon leucocytaire humain et procede de formation d'hybrides cellulaires producteurs d'anticorps specifiques de l'interferon humain |
-
1982
- 1982-01-22 FI FI820200A patent/FI820200A7/fi not_active Application Discontinuation
- 1982-01-26 SE SE8200403A patent/SE8200403L/ not_active Application Discontinuation
- 1982-01-27 GB GB8202247A patent/GB2092614A/en not_active Withdrawn
- 1982-01-27 DK DK37382A patent/DK37382A/da unknown
- 1982-01-28 FR FR8201317A patent/FR2498626A1/fr not_active Withdrawn
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0096839A1 (en) * | 1982-06-09 | 1983-12-28 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for producing human antibody |
| US4833077A (en) * | 1982-06-09 | 1989-05-23 | Asahi Kasei Kogyo Kabashiki Kaisha | Method for producing human antibody |
| EP0119859A3 (en) * | 1983-03-18 | 1986-12-17 | Kyowa Hakko Kogyo Kabushiki Kaisha | Monoclonal antibodies, processes for their preparation and methods for their use |
| EP0122628A3 (en) * | 1983-04-15 | 1986-03-26 | Amgen Inc. | Monoclonal antibodies to human immune interferon |
| US4599306A (en) * | 1983-04-15 | 1986-07-08 | Amgen | Monoclonal antibodies which specifically bind to human immune interferon |
| EP0462623A1 (en) * | 1983-04-15 | 1991-12-27 | Amgen Inc. | Monoclonal antibodies to human immune interferon |
| GB2194240A (en) * | 1986-07-25 | 1988-03-02 | Hayashibara Biochem Lab | Preparation of interferon-gamma |
| GB2194240B (en) * | 1986-07-25 | 1990-09-19 | Hayashibara Biochem Lab | Preparation and uses of interferon-gamma |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2498626A1 (fr) | 1982-07-30 |
| SE8200403L (sv) | 1982-07-29 |
| DK37382A (da) | 1982-07-29 |
| FI820200L (fi) | 1982-07-29 |
| FI820200A7 (fi) | 1982-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saksela et al. | Human natural killer cell activity is augmented by interferon via recruitment of ‘pre‐NK’cells | |
| Goding | Antibody production by hybridomas | |
| EP0790255B1 (en) | Monoclonal antibodies directed to the cytotoxic lymphocyte maturation factor | |
| FI75183C (fi) | Foerfarande foer framstaellning av en komplement-bindande monoklonal antikropp mot maenniskans t-celler genom anvaendning av en ny hybridcellinje. | |
| EP0014519B1 (en) | Cell lines, process for preparing them and process for producing antibodies | |
| US5011778A (en) | Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies | |
| US4946788A (en) | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications | |
| JPH0471520B2 (fi) | ||
| FI75364B (fi) | Foerfarande foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och suppressor-t-celler medelst en ny hybridcellinje. | |
| EP0158420B1 (en) | Monoclonal antibodies to interferon alpha 2 and hybridomas producing such antibodies | |
| Dardenne et al. | Monoclonal antibody against the serum thymic factor (FTS) | |
| US5677182A (en) | Cleavage site blocking antibody to prohormone proteins and uses thereof | |
| Ralph et al. | Functions of macrophage cell lines | |
| EP0367596B1 (en) | Antagonist to interleukin-5 for preventing or reducing eosinophilia | |
| GB2092614A (en) | Process for the manufacture of hybrid cells producing an antibody in which methylcellulose is used in the selection of hydrides | |
| CA1330768C (en) | Monoclonal anti-human granulocyte colony stimulating factor antibody | |
| AU603053B2 (en) | Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
| EP0409901A1 (en) | Lak cell cytotoxin | |
| Levy et al. | Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma | |
| Springer et al. | Functional and structural interrelationships among the Mac-1, LFA-1 family of leukocyte adhesion glycoproteins, and their deficiency in a novel heritable disease | |
| EP0305960A2 (en) | A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use | |
| EP0118311A2 (en) | Monoclonal factor having 5'-nucleotidase inhibitory activity | |
| EP0234545A2 (en) | Purified human angiogenic factor, method for its preparation and pharmaceutical preparations | |
| DE3200657A1 (de) | Verfahren zur herstellung von einen antikoerper produzierenden hybridzellen und von antikoerpern, hybridzellen und antikoerper | |
| Grillot‐Courvalin et al. | Induction of suppressive cells within the T4 subset by a human T‐T hybridoma‐produced factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |